Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Oberg

Showing results (221-230 of 257) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Science (New York, N.Y.)|March 3, 2009
A transposon-based genetic screen in mice identifies genes altered in colorectal cancerTimothy K Starr, Raha Allaei, Kevin A T Silverstein, et al.
Cancers|December 10, 2021
CHFR and Paclitaxel Sensitivity of Ovarian CancerAndrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, et al.
Nature Communications|February 24, 2017
Cellular senescence mediates fibrotic pulmonary diseaseMarissa J Schafer, Thomas A White, Koji Iijima, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2025
Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinomaXiaonan Hou, Valentina Zanfagnin, Conway Xu, et al.
Experimental Hematology & Oncology|June 23, 2025
Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivityRachel M Hurley, Jill M Wagner, Arun Kanakkanthara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2019
Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 StudyFei Chen, Erica J Childs, Evelina Mocci, et al.
Gynecologic Oncology|January 29, 2019
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancerRachel M Hurley, Andrea E Wahner Hendrickson, Daniel W Visscher, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Pageof 26

Showing results (221-230 of 257) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2014
Tumorgrafts as in vivo surrogates for women with ovarian cancerS John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, et al.
Science (New York, N.Y.)|March 3, 2009
A transposon-based genetic screen in mice identifies genes altered in colorectal cancerTimothy K Starr, Raha Allaei, Kevin A T Silverstein, et al.
Cancers|December 10, 2021
CHFR and Paclitaxel Sensitivity of Ovarian CancerAndrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, et al.
Nature Communications|February 24, 2017
Cellular senescence mediates fibrotic pulmonary diseaseMarissa J Schafer, Thomas A White, Koji Iijima, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2025
Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinomaXiaonan Hou, Valentina Zanfagnin, Conway Xu, et al.
Experimental Hematology & Oncology|June 23, 2025
Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivityRachel M Hurley, Jill M Wagner, Arun Kanakkanthara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular SubtypesStefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2019
Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 StudyFei Chen, Erica J Childs, Evelina Mocci, et al.
Gynecologic Oncology|January 29, 2019
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancerRachel M Hurley, Andrea E Wahner Hendrickson, Daniel W Visscher, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Pageof 26